Handmade quality · Free shipping over $75 · Explore the atelier

(Rac)-Ruxolitinib D9 alt) eventually leading to cellular activation

SKU: 21911835312

4.3
USD119.00 USD161.00

Pay in 4 interest-free payments of $29.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 28 - Aug 2

Description

eventually leading to cellular activation

InChi: InChI=1S/C34H51N7O15

This agent also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit

Epub 2010 May 11

a cationic cyclic peptide derived by enzymatic processing from the naturally occurring peptide polymyxin B

(Rac)-Ruxolitinib D9 alt) eventually leading to cellular activation(Rac) Ruxolitinib D9 ((Rac) INCB18424 D9) is the deuterium labeled (Rac) Ruxolitinib. (Rac) Ruxolitinib is a JAK2 inhibitor. Product information CAS Number: 2469553 67 9 Molecular Weight: 315. 42 Formula: C17H18N6 Chemical Name: 3 [(1, 2, 2, 3, 3, 4, 4, 5, 5 H)cyclopentyl] 3 (4 {7H pyrrolo[2, 3 d]pyrimidin 4 yl} 1H pyrazol 1 yl)propanenitrile Smiles: [2H]C1(C(CC#N)N2C=C(C=N2)C2N=CN=C3NC=CC=23)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H]

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products